Announcements Trials
Browse Landscape

Phase

Phase 1/2 10Phase 2 7Phase 1 6Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 3Recurrence 1Neoplasms, Plasma Cell 1Neoplasm, Residual 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Carcinoma, Hepatocellular 1Amyloidosis 1

Interventions

fludarabine 2Cyclophosphamide 2zanubrutinib 1pegfilgrastim 1obinutuzumab 1fludarabine phosphate 1Specimen Handling 1Resistance Training 1Radiotherapy 1Neuropsychological Tests 1Modafinil 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Injections 1Filgrastim 1Contrast Media 1Blood Specimen Collection 1Azacitidine 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, B-Cell × Lenalidomide × Clear all
NCT05797948 2023-04-04

GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

The First Affiliated Hospital of Soochow University

Phase NA Unknown
20 enrolled
Lymphoid

Recurrence, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡